September 1, 2021
A study measured effectiveness of COVID-19 mRNA vaccines among health workers, most notably during the emergence of delta virus variant and coincident with end of state’s mask mandate, finding protection waned over time, dropping sharply 6-8 months after full vaccination.
February 17, 2021
Leading scientific and medical experts, including researchers from the University of California San Diego, are calling upon the Biden Administration to take immediate action to address inhalation exposure to the SARS-CoV-2 virus as a cornerstone of the COVID-19 pandemic response.
July 3, 2012
Popularly dubbed “the book of life,” the human genome is extraordinarily difficult to read. In a paper published in the July 1, 2012 issue of the journal Nature, researchers at the Ludwig Institute for Cancer Research and the University of California, San Diego School of Medicine open the book further,…
September 3, 2020
UC San Diego Health is the first hospital in San Diego and only health care system in Southern California to transplant a liver from a donor with Human Immunodeficiency Virus (HIV) into an HIV-positive recipient. The surgery is part of a national clinical trial.
February 16, 2017
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterial scourge that is resistant to most common antibiotics and thus difficult to treat, particularly in children where it commonly causes complicated skin and skin structure infections. In a randomized, controlled clinical trial — the first of its kind — a multi-institution research team…
March 26, 2020
…24, the Centers for Disease Control and Prevention (CDC) reported a total of 1,931 cases in California as a result of the pandemic. In his prime-time talk to Californians, Newsom said that there has been unacceptable xenophobia and racism directed at Asians and Asian-Americans amid the outbreak. He noted that…
January 18, 2018
…access to primary care, disease prevention and early interventions that can both improve public health and lower the total cost of health care.” “We need primary care to address public health crises like obesity and diabetes, and we need physician payer models that incentivize keeping patients healthy,” he said. In…
May 16, 2022
COVID-19, MIS-C and KD all share a similar underlying mechanism involving the over-activation of particular inflammatory pathways, UC San Diego study shows. Findings support novel drug targets for MIS-C.
January 8, 2019
FDA approves first U.S. clinical trial of an intravenously administered bacteriophage-based therapy to treat resistant bacterial infections.
December 28, 2022
UC San Diego study reveals critical insights into the complex biology of tissue-specific T cells, paving the way for a new branch of precision therapeutics in immunity, autoimmunity, and cancer.
